Close

Impax Laboratories Inc. (IPXL) Tops Q2 EPS by 16c

July 31, 2012 7:13 AM EDT
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q2 EPS of $0.60, $0.16 better than the analyst estimate of $0.44. Revenue for the quarter came in at $166.5 million versus the consensus estimate of $162.03 million.

For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings